{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:36:06Z","timestamp":1760160966353},"reference-count":59,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.2217\/imt.10.46","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T10:51:55Z","timestamp":1285757515000},"page":"697-709","source":"Crossref","is-referenced-by-count":15,"title":["Antimelanoma Immunotherapy: Clinical and Preclinical Applications of Il-12 Family Members"],"prefix":"10.1080","volume":"2","author":[{"given":"Hiroshi","family":"Nagai","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Oniki","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Intractable Disease Research Center, Tokyo Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17951-3"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812223192527"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65321-7"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2005.06.002"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2616"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.9.6062"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050930"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701046"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.1444"},{"issue":"5","key":"e_1_3_2_3_10_1","first-page":"1115","article-title":"Utility of tumour-infiltrating CD25+Foxp3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.","volume":"18","author":"Miracco C","year":"2007","unstructured":"Miracco C , MourmourasV, BiagioliMet al.: Utility of tumour-infiltrating CD25+Foxp3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.Oncol. Rep.18(5) , 1115\u20131122 (2007).","journal-title":"Oncol. Rep."},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.3.827"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00070-4"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00324-2"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00715.x"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00714.x"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.098"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.4.2191"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1375"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1376"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4415"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636896"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1537"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1540"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1541"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.4.1223"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.8.581"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0306212"},{"issue":"3","key":"e_1_3_2_3_29_1","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.","volume":"3","author":"Atkins MB","year":"1997","unstructured":"Atkins MB , RobertsonMJ, GordonMet al.: Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.Clin. Cancer Res.3(3) , 409\u2013417 (1997).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"e_1_3_2_3_30_1","first-page":"75","volume":"4","author":"Bajetta E","year":"1998","unstructured":"Bajetta E , Del Vecchio M, Mortarini R et al.: Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res.4(1) , 75\u201385 (1998).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0776"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.18.3836"},{"key":"e_1_3_2_3_33_1","first-page":"7","article-title":"Two Phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.","volume":"3","author":"Cebon J","year":"2003","unstructured":"Cebon J , J\u00e4gerE, ShackletonMJet al.: Two Phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.Cancer Immun.3 , 7 (2003).","journal-title":"Cancer Immun."},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.144"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1450"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2283"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.35"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652305774964712"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6794"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804166"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.11.1705"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2009.33"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.600"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4087"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2004.08.001"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7571"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.9.5213"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1682"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3448"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04808"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2084"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1686"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7317"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.02.025"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02111.x"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2793"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24107"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4311"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.10.6527"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.10.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:31:22Z","timestamp":1715945482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.10.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.2217\/imt.10.46"],"URL":"https:\/\/doi.org\/10.2217\/imt.10.46","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}